Angela Hartley Brodie, Ph.D. is professor of pharmacology and experimental therapeutics at the University of Maryland School of Medicine. She works in the University of Maryland Greenebaum Cancer Center's Hormone Responsive Cancers research program. Dr. Brodie is renowned for her groundbreaking work in the development of aromatase inhibitors used in the treatment of breast cancer.
In June 2005, she received the prestigious Charles F. Kettering Prize from the General Motors Cancer Research Awards. The international prize recognizes the most recent contribution to the diagnosis or treatment of cancer. Dr. Brodie was the first woman to receive the $250,000 award.[1]
College Degree: B.Sc. (Hons) Sheffield University, UK Post Doctoral Degree: Ph.D. Manchester University, UK Fellowship: NIH Fellowship in Steroid Biochemistry, Clark University, MA